Sectors
GENB
Generate Biomedicines, Inc.
15.27
2 x 11.10
2 x 19.13
bid
ask
-
0.06
0.39%
2 @ 07:44 PM
15.35 +0.08 (0.52%)
| Ytd | 20.71% | |
| 1y | 20.71% |
14.77
day range
15.63
11.00
52 week range
22.67
| Open | 15.27 | Prev Close | 15.33 | Low | 14.77 | High | 15.63 | Mkt Cap | 1.96B |
| Vol | 1.55M | Avg Vol | 1.02M | EPS | -2.09 | P/E | N/A | Forward P/E | -6.70 |
| Beta | N/A | Short Ratio | 14.88 | Inst. Own | 77.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 15.22 | 200-d Avg | 13.84 | 1yr Est | 26.00 |
| Income Statement | |||
| Total Revenue | 6.31M | ||
| Revenues (USD) | 6.31M | ||
| Gross Profit | 6.31M | ||
| Operating Expenses | 77.93M | ||
| Research and Development Expense | 64.33M | ||
| Selling, General and Administrative Expense | 13.60M | ||
| Operating Income | -71.61M | ||
| Interest Expense | 155.00K | ||
| Income Tax Expense | 53.00K | ||
| Net Income | -67.25M | ||
| Net Income Common Stock | -67.25M | ||
| Net Income Common Stock (USD) | -67.25M | ||
| Consolidated Income | -67.25M | ||
| Earnings per Basic Share | -0.52 | ||
| Earnings per Basic Share (USD) | -0.52 | ||
| Earnings per Diluted Share | -0.52 | ||
| Earning Before Interest & Taxes (EBIT) | -67.05M | ||
| Earning Before Interest & Taxes (USD) | -67.05M | ||
| Weighted Average Shares | 128.24M | ||
| Weighted Average Shares Diluted | 128.24M | ||
| Balance Sheet | |||
| Cash and Equivalents | 135.36M | ||
| Cash and Equivalents (USD) | 135.36M | ||
| Investments | 322.06M | ||
| Investments Current | 322.06M | ||
| Current Assets | 470.25M | ||
| Property, Plant & Equipment Net | 82.38M | ||
| Total Assets | 561.69M | ||
| Debt Current | 13.62M | ||
| Total Debt | 62.63M | ||
| Current Liabilities | 56.64M | ||
| Debt Non-Current | 49.01M | ||
| Total Liabilities | 105.65M | ||
| Accumulated Retained Earnings (Deficit) | -804.99M | ||
| Accumulated Other Comprehensive Income | -129.00K | ||
| Shareholders Equity | 456.05M | ||
| Shareholders Equity (USD) | 456.05M | ||
| Assets Non-Current | 91.44M | ||
| Total Debt (USD) | 62.63M | ||
| Deferred Revenue | 12.17M | ||
| Liabilities Non-Current | 49.01M | ||
| Trade and Non-Trade Payables | 5.65M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 5.92M | ||
| Net Cash Flow from Financing | -579.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -25.21M | ||
| Capital Expenditure | -933.00K | ||
| Issuance (Purchase) of Equity Shares | 414.00K | ||
| Issuance (Repayment) of Debt Securities | -993.00K | ||
| Net Cash Flow from Investing | 33.31M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 34.24M | ||
| Net Cash Flow from Operations | -57.94M | ||
| Share Based Compensation | 8.24M | ||